Skeletal anomalies of gabapentin in pregnant female albino rats

ABSTRACT

Gabapentin is one of the new antiepileptic drugs. The aim of this study was to evaluate the skeletal anomalies of gabapentin in pregnant female albino rats. Thirty virgin female albino rats were used and classified into three equal groups each consisted of 10 rats. The first group received nothing except regular diet and tap water and considered as negative control. The second group received 1 ml saline daily orally from the 1st day till the 20th day of gestation. The third group received gabapentin in a single dose of 324 mg/kg body weight in 1 ml saline orally daily from the 1st day to the 20th day of gestation. On the 20th day of pregnancy, rats were sacrificed and the uterine horns promptly exposed, the number of alive fetuses was detected as well as the number of fetal resorptions. Individual fetal weight, crown- rump length [CRL] and bipareital diameter were recorded. Then fetuses were eviscerated and placed into alizarin red stain for detection of osseous skeleton. The numbers of fetal resorptions in the negative and positive control rats were 5% and 4.6% respectively. The number of fetal resorptions in gabapentin treated dams was 42%. The numbers of examined alive fetuses were 85, 82, and 28 in negative control, positive control and gabapentin treated rats respectively. There were significant decrease in the weight, CRL and bipareital diameter measures in fetuses of third group [gabapentin treated] compared to those in the first group [negative control]. Fetuses stained with alizarin stain of dams treated with gabapentin revealed incomplete ossification of skull bones as parietal, interpareital, occipital, frontal, lacrimal and occipital bones. Also, there were incomplete ossifications of vertebral, metacarpal and metatarsal bones. It can be concluded that gabapentin is experimentally a teratogenic drug. It can be recommended that further studies must be done to evaluate teratogenicity of gabapentin in humans. Mothers taking it during pregnancy have to check regularly their fetuses till the end of pregnancy. But it is preferred that those women should be advised to use a contraceptive method during treatment with this drug to avoid its teratogenic effect